Long-Term PPI Safety in Children: Nutrient Absorption, Bone Health, and Gut Flora

Proton pump inhibitors (PPIs) are medicines that reduce stomach acid. Common examples include omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole. Doctors may prescribe them for conditions such as gastroesophageal reflux disease (GERD), inflammation of the esophagus, stomach ulcers, or certain uncommon disorders that cause excessive acid production.

The question of long term PPI safety in children is important because stomach acid has useful roles in digestion, mineral absorption, and protection against some infections. At the same time, PPIs can be highly effective and appropriate when a child has a clear medical need. The goal is not to avoid these medicines at all costs, but to use the right medicine, at the right dose, for the right length of time.

What does “long term” mean?

There is no single definition used for every child. A course lasting a few weeks is usually considered short term, while treatment continuing for several months or longer deserves regular review. The risks may also depend on:

• The child’s age and general health
• The PPI dose
• Whether the medicine is taken daily
• The reason for treatment
• Diet and existing nutrient levels
• Other medicines or medical conditions
• A history of bone problems, kidney disease, or repeated infections

Pediatric gastroenterology guidelines generally recommend using PPIs for a clear indication and reassessing the need regularly. Infants and children should not be kept on a PPI simply because of unexplained fussiness, ordinary spit-up, or symptoms that have not been properly evaluated.

Nutrient absorption

Stomach acid helps release some nutrients from food and supports the absorption of certain vitamins and minerals. Long-term acid suppression has therefore raised concerns about deficiencies in magnesium, iron, vitamin B12, and calcium.

Magnesium

Low magnesium levels are a recognized, but uncommon, concern with prolonged PPI use. Symptoms can include muscle cramps, weakness, tremors, abnormal heart rhythms, or seizures. The risk appears higher in people taking other medicines that lower magnesium, such as some diuretics, or in those with kidney problems.

Routine magnesium testing is not necessary for every child taking a PPI. A doctor may consider a blood test if treatment is prolonged, the child has risk factors, or symptoms suggest a deficiency.

Iron and vitamin B12

Stomach acid contributes to the release and absorption of iron from food. It also helps the body process vitamin B12 from animal-based foods. Adult studies have found associations between long-term PPI use and low levels of these nutrients, but evidence in children is more limited and inconsistent.

A healthy child eating a varied diet is unlikely to develop a deficiency solely because of a PPI. However, testing may be sensible if a child has anemia, poor growth, a restricted diet, inflammatory bowel disease, malabsorption, or other reasons for low nutrient levels. Parents should not start iron or high-dose vitamin supplements without medical advice, since unnecessary supplements can cause side effects and may mask the real cause of a problem.

Calcium

The effect of PPIs on calcium absorption in children is not fully established. Some research suggests that reduced acid may affect the absorption of certain forms of calcium, while other studies have not shown a meaningful effect in healthy children. Most children can maintain adequate calcium intake through food, even when taking a PPI.

Good sources include milk, yogurt, cheese, calcium-fortified plant drinks, tofu made with calcium, and some leafy greens. Vitamin D is also important for bone health. A doctor can advise whether a child needs testing or supplementation based on diet, growth, medical history, and risk factors.

Bone health and fracture risk

Some large observational studies have reported a small increase in fracture risk among children who use PPIs, particularly with longer treatment or higher cumulative exposure. The possible increase has been seen in fractures involving the wrist, arm, or other bones.

These studies do not prove that PPIs directly cause fractures. Children prescribed PPIs may already have conditions that affect nutrition, activity, growth, or bone strength. Some may also use steroids or other medicines that influence bone health. This makes it difficult to separate the effect of the PPI from the child’s underlying health.

Current evidence does not suggest that every child taking a PPI will develop weak bones. Still, prolonged treatment should be reviewed, especially in a child who has:

• Previous fractures from minor injuries
• Poor growth or low body weight
• Limited mobility
• Low vitamin D or calcium intake
• Kidney, liver, or intestinal disease
• Long-term steroid treatment
• A condition known to affect bone density

Regular physical activity appropriate for the child’s age, a balanced diet, adequate calcium and vitamin D, and avoidance of smoking exposure all support healthy bones. Bone-density scans are not routinely needed for children taking PPIs, but a specialist may recommend one when other risk factors are present.

Effects on gut flora and infections

Stomach acid is one of the body’s natural defenses against swallowed bacteria. By reducing acidity, PPIs may change which organisms survive and reach the intestine. Research has found changes in the gut microbiome in some children and adults using acid-suppressing medicines.

The long-term meaning of these changes is still being studied. A changed microbiome is not automatically harmful, and there is no established “ideal” gut flora test that should be performed for every child on a PPI.

PPI use has been associated in some studies with a higher risk of gastrointestinal infections, including Clostridioides difficile, and possibly some respiratory infections. The absolute risk for an individual child is generally low, but it may be more relevant in children who are hospitalized, immunocompromised, have repeated antibiotic exposure, or have complex medical conditions.

Parents should contact a doctor if a child develops persistent or severe diarrhea, blood in the stool, dehydration, ongoing fever, severe abdominal pain, or repeated infections. Do not give anti-diarrhea medicines to a young child without professional advice.

How to use PPIs more safely

A doctor should confirm that a PPI is needed and choose the dose based on the child’s weight, diagnosis, and treatment response. Helpful safety steps include:

• Use the lowest effective dose.
• Continue treatment for the shortest appropriate period.
• Attend planned medication reviews.
• Do not share a PPI or use an old prescription for a new illness.
• Give the medicine exactly as directed; some formulations must not be crushed.
• Ask before combining it with other medicines or supplements.
• Do not stop a long-term PPI suddenly without guidance, because temporary rebound acid symptoms can occur.

If symptoms return whenever the medicine is stopped, that does not always mean the child needs lifelong treatment. It may reflect rebound acid production, an untreated underlying condition, or an incorrect diagnosis. A doctor can decide whether to taper the dose, change treatment, investigate further, or continue the PPI.

Families who are unsure how urgent symptoms may be can consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help organize symptoms and suggest appropriate next steps, but it does not replace an examination or diagnosis by a qualified clinician.

When to speak to a doctor

Speak to a doctor before starting, stopping, or extending a child’s PPI treatment. Ask for a review if the medicine has been used for several months, symptoms are not improving, or the child needs repeated courses.

Seek prompt medical care for trouble breathing or swallowing, vomiting blood, black stools, severe or worsening abdominal pain, persistent vomiting, fainting, marked weakness, signs of dehydration, unexplained weight loss, or poor growth. Anything that could be life threatening or serious should be assessed urgently by a doctor or emergency service.

Overall, PPIs are not automatically unsafe for children. When clearly indicated, they can prevent painful inflammation and serious complications. The main concern is unnecessary or unreviewed long-term use. Regular reassessment, attention to nutrition and bone health, and monitoring based on the child’s individual risk factors offer a sensible approach to long-term PPI safety in children.